Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34,116
Closed -$481K 1691
2026
Q1
$481K Buy
34,116
+8,642
+34% +$103K ﹤0.01% 1201
2025
Q4
$235K Buy
+25,474
New +$221K ﹤0.01% 1365
2025
Q3
Sell
-70,974
Closed -$684K 1664
2025
Q2
$684K Sell
70,974
-2,110
-3% -$19.5K 0.01% 1065
2025
Q1
$642K Sell
73,084
-2,868
-4% -$24.1K 0.01% 1049
2024
Q4
$593K Buy
+75,952
New +$578K ﹤0.01% 1106
2023
Q2
Sell
-91,121
Closed -$1.27M 1945
2023
Q1
$1.27M Buy
91,121
+49,335
+118% +$709K 0.01% 1058
2022
Q4
$550K Sell
41,786
-8,151
-16% -$109K 0.01% 1136
2022
Q3
$701K Buy
+49,937
New +$809K 0.01% 1248

Other funds holding EHAB

Michael Gelband's EHAB Position: Q2 2026 in Review

Michael Gelband sold out of Enhabit (EHAB) in Q2 2026, closing a stake of 34,116 shares — an estimated $481K sold.

Michael Gelband first reported a position in EHAB in Q3 2022 and held it in 8 quarters. The position peaked at $1.27M in Q1 2023. 1 fund tracked by Wall St. Rank holds EHAB as of Q2 2026.

  • Michael Gelband reported no remaining Enhabit position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 34,116 Enhabit shares in Q2 2026, an estimated $481K.
  • Michael Gelband first reported a position in Enhabit in Q3 2022 and held it in 8 quarters.
  • Michael Gelband's Enhabit position peaked at $1.27M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Enhabit as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.